Nineteen African states—those currently reporting or that have reported Mpox cases within this outbreak—gathered in a ‘back-to-school’ style meeting in Congo Brazzaville in the first week of November.

Vaccines currently available to the global market are Bavarian Nordic’s MVA-BN (JYNNEOS), KM Biologics’ LC16, and Emergent ...